MoonLake Immunotherapeutics

MLTX · Healthcare · MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseas…

MoonLake Immunotherapeutics (MLTX), in the Healthcare sector, has 15 disclosed filings on Paydirt over the trailing twelve months from 5 corporate insiders: 0 purchases and 15 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jul 21 and filed Jul 23. The most active filer was Kristian Reich with 5 filings.

Add to watchlist

Filings, ttm

0 buys · 15 sells · 1 late

Traders, ttm

5 insiders

Volume, ttmiDollar value disclosed in the window

$129.6M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jul 21

Filed Jul 23

ADViAverage daily dollar volume

$19.7M

market data

Share price · 12M

$17.99 (-67.3%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $240.0M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Kristian Reich Chief Scientific Officer 5 filings MB

Matthias Bodenstedt Chief Financial Officer 4 filings DS

da Silva Jorge Santos Chief Executive Officer 4 filings BL Bvf I Gp Llc Director 1 filing CL Cormorant Global Healthcare Master Fund, LP Other 1 filing ML

Mark N Lampert Director 1 filing CM

Catherine Moukheibir Director 1 filing SS

Simon Sturge Director 1 filing

Recent filings

Kristian ReichSALE Chief Scientific Officer $1.0M
50,000 sh × $20.02
Exec Jul 21
Filed Jul 23 · 4:05 PM ET Kristian ReichSALE Chief Scientific Officer $878K
43,700 sh × $20.09
Exec Jul 20
Filed Jul 21 · 6:13 PM ET Kristian ReichSALE Chief Scientific Officer $322K
16,105 sh × $20.01
Exec Jul 15
Filed Jul 20 · 6:07 AM ET † da Silva Jorge SantosSALE Chief Executive Officer $2.0M
102,225 sh across 2 lots
Exec Jul 9
Filed Jul 13 · 4:10 PM ET da Silva Jorge SantosSALE Chief Executive Officer $957K
47,775 sh × $20.03
Exec Jul 1
Filed Jul 2 · 4:10 PM ET Matthias BodenstedtSALE Chief Financial Officer $862K
39,120 sh × $22.04
Exec Jun 22
Filed Jun 23 · 5:30 PM ET Matthias BodenstedtSALE Chief Financial Officer $297K
15,082 sh × $19.68
Exec Jun 17
Filed Jun 18 · 5:30 PM ET Kristian ReichSALE Chief Scientific Officer $2.9M
150,000 sh across 3 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET Matthias BodenstedtSALE Chief Financial Officer $273K
13,653 sh × $20.02
Exec May 11
Filed May 13 · 5:30 PM ET da Silva Jorge SantosSALE Chief Executive Officer $2.8M
150,000 sh across 2 lots
Exec Apr 10
Filed Apr 14 · 5:30 PM ET Matthias BodenstedtSALE Chief Financial Officer $1.6M
85,870 sh × $18.94
Exec Apr 9
Filed Apr 10 · 5:30 PM ET Mark N LampertSALE Director $63.0M
3,750,000 sh across 3 lots
Exec Mar 31
Filed Apr 2 · 5:30 PM ET Kristian ReichSALE Chief Scientific Officer $3.0M
202,908 sh across 2 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET da Silva Jorge SantosSALE Chief Executive Officer $3.0M
200,000 sh across 2 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Cormorant Global Healthcare Master Fund, LPSALE Other $46.8M
6,494,151 sh across 4 lots
Exec Sep 29 2025
Filed Oct 1 2025 · 5:30 PM ET Catherine MoukheibirSALE Director $1.1M
23,500 sh × $48.79
Exec Jul 3 2025
Filed Jul 7 2025 · 5:30 PM ET Simon SturgeSALE Director $9.2M
171,000 sh × $53.72
Exec Oct 4 2024
Filed Oct 8 2024 · 5:30 PM ET Bvf I Gp LlcSALE Director $100.0M
2,000,000 sh across 3 lots
Exec Oct 4 2024
Filed Oct 8 2024 · 5:30 PM ET